AccuGrowth bought more INSM shares today and has upgraded his sentiment to BUY.
Investors who purchases in the $.60 to $.79 range and are willing to hold INSM shares for 2 or more years have a good chance of being rewarded versus the risk of any serious erosion in the stock price. The risk of delistment from the NASDAQ GM is basically priced in at this point.
Today's volume indicated that there are investors out there willing to pick up shares of INSM on any weakness. INSM is due to report on several projects soon to include:
ROP -results of P1 study from Harvard/Switzerland
HARS -results are expected to be good
ALS -Q4 income from Italy is expected to increase indicating additional patients winning court approval and the initiation of increased dosing is proceeding, plus IPLEX continues to be well tolerated
MMD -Fall of 2008 with an earlier announcement that the study is fully subscribed anytime soon
FOB -Management is expected to indicate that talks are still ongoing with a revised target of H2 of 2008
Prostate Cancer -a positive study has been published in a professional journal but a news release has not been distributed yet
I want to use a baseball analogy to compare INSM pumper versus my investing wisdom.
The pumpers claim we are in the bottom of the second inning with bases loaded (HARS, ROP, ALS) and FOB up to bat (MMD scored a P2 trial already). The pumpers are expecting a home run.
I think FOB struck out at the end of 2007. We are in the top of the third inning. NASDAQ delisting is in the batter's box and Allen is the pitcher. I expect a pop fly (a hand slap to INSM and movement to the NASDAQ CM). The sides will change. HARS will be first to bat. HARS, ROP, and ALS will need to work their way back to base with positive news releases before the INSM investor fans will take notice and pay up for more shares.
FOB is a designated hitter. The rules for designated hitters are a secret in this game. So no clarity when FOB may get another chance until the coach says something.
The coach has a Q4 conference call coming up in a few weeks. If you are gonna dream, make it interesting.